Flucelvax
NDC 70461-656, INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), injection, suspension, from Seqirus Inc..
- Product NDC
- 70461-656
- Status
- Listed
- Labeler
- Seqirus Inc.
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125408
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70461-656 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLUENZA A VIRUS A/TASMANIA/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
- INFLUENZA A VIRUS A/TASMANIA/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
- INFLUENZA B VIRUS - B/ARIZONA/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70461-656-03 | 70461065603 | 10 SYRINGE, GLASS in 1 CARTON (70461-656-03) / .5 mL in 1 SYRINGE, GLASS (70461-656-04) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70461-656 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70461-656 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70461-656. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.